Brandon M. Nathan

3.6k total citations
61 papers, 1.9k citations indexed

About

Brandon M. Nathan is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Brandon M. Nathan has authored 61 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Endocrinology, Diabetes and Metabolism, 24 papers in Genetics and 23 papers in Surgery. Recurrent topics in Brandon M. Nathan's work include Diabetes Management and Research (26 papers), Pancreatic function and diabetes (20 papers) and Diabetes and associated disorders (19 papers). Brandon M. Nathan is often cited by papers focused on Diabetes Management and Research (26 papers), Pancreatic function and diabetes (20 papers) and Diabetes and associated disorders (19 papers). Brandon M. Nathan collaborates with scholars based in United States, Australia and Italy. Brandon M. Nathan's co-authors include Antoinette Moran, William Thomas, Jordan Dunitz, Asad Saeed, Aaron S. Kelly, Claudia K. Fox, Kyle Rudser, Mark R. Palmert, M. Jennifer Abuzzahab and Theresa A. Laguna and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Brandon M. Nathan

58 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brandon M. Nathan United States	22	860	554	464	393	268	61	1.9k
Tycho Lock Netherlands	19	447 0.5×	226 0.4×	497 1.1×	104 0.3×	134 0.5×	36	1.5k
Raoul Rooman Belgium	25	589 0.7×	292 0.5×	234 0.5×	432 1.1×	163 0.6×	57	1.7k
Lauren Nathan United States	18	881 1.0×	245 0.4×	118 0.3×	742 1.9×	321 1.2×	26	2.2k
Pauli Karhapää Finland	26	853 1.0×	433 0.8×	197 0.4×	180 0.5×	154 0.6×	38	2.1k
Assimina Galli‐Τsinopoulou Greece	22	324 0.4×	323 0.6×	256 0.6×	346 0.9×	156 0.6×	111	1.5k
D. J. Carson United Kingdom	23	690 0.8×	509 0.9×	206 0.4×	627 1.6×	68 0.3×	69	1.7k
Marta Hernández Spain	23	549 0.6×	387 0.7×	151 0.3×	223 0.6×	138 0.5×	87	1.5k
Nele Friedrich Germany	20	885 1.0×	286 0.5×	80 0.2×	129 0.3×	203 0.8×	52	1.6k
Roy A. Kaplan United States	18	768 0.9×	437 0.8×	444 1.0×	300 0.8×	54 0.2×	26	2.1k
Demetrios Rizos Greece	24	481 0.6×	170 0.3×	169 0.4×	150 0.4×	303 1.1×	106	1.8k

Countries citing papers authored by Brandon M. Nathan

Since Specialization

Citations

This map shows the geographic impact of Brandon M. Nathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandon M. Nathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandon M. Nathan more than expected).

Fields of papers citing papers by Brandon M. Nathan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandon M. Nathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandon M. Nathan. The network helps show where Brandon M. Nathan may publish in the future.

Co-authorship network of co-authors of Brandon M. Nathan

This figure shows the co-authorship network connecting the top 25 collaborators of Brandon M. Nathan. A scholar is included among the top collaborators of Brandon M. Nathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandon M. Nathan. Brandon M. Nathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sims, Emily K., David Cuthbertson, Lauric Ferrat, et al.. (2025). IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes. Diabetologia. 68(5). 993–1004. 2 indexed citations

Sims, Emily K., David Cuthbertson, Laura M. Jacobsen, et al.. (2024). Comparisons of Metabolic Measures to Predict T1D vs Detect a Preventive Treatment Effect in High-Risk Individuals. The Journal of Clinical Endocrinology & Metabolism. 109(8). 2116–2123. 4 indexed citations

Marka, Nicholas, et al.. (2024). Insulin-like growth factor-1 and insulin-like growth factor binding protein-3 as early predictors of growth, body composition, and neurodevelopment in preterm infants. Journal of Perinatology. 44(11). 1617–1623. 1 indexed citations

Galderisi, Alfonso, Emily K. Sims, Carmella Evans‐Molina, et al.. (2024). Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab. Diabetologia. 68(3). 646–661. 2 indexed citations

Sosenko, Jay M., David Cuthbertson, Emily K. Sims, et al.. (2023). Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet Autoantibodies. Diabetes Care. 46(5). 1098–1105. 9 indexed citations

Fox, Claudia K., Justin Clark, Kyle Rudser, et al.. (2022). Exenatide for weight‐loss maintenance in adolescents with severe obesity: A randomized, placebo‐controlled trial. Obesity. 30(5). 1105–1115. 29 indexed citations

Sims, Emily K., David Cuthbertson, Jamie L. Felton, et al.. (2022). Persistence of β-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at Screening. Diabetes Care. 45(12). 2982–2990. 5 indexed citations

Petryk, Anna, Lei Zhang, Todd E. DeFor, et al.. (2016). Endocrinopathies, Bone Health, and Insulin Resistance in Patients with Fanconi Anemia after Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 22(8). 1487–1492. 15 indexed citations

Kelly, Aaron S., et al.. (2016). Weight Loss Mediated Reduction in Xanthine Oxidase Activity and Uric Acid Clearance in Adolescents with Severe Obesity. Childhood Obesity. 12(4). 286–291. 19 indexed citations

10.

Forlenza, Gregory P., Kenneth B. Beckman, Tanya Halvorsen, et al.. (2015). Next generation sequencing in endocrine practice. Molecular Genetics and Metabolism. 115(2-3). 61–71. 17 indexed citations

11.

Petryk, Anna, Roopa Kanakatti Shankar, Neelam Giri, et al.. (2015). Endocrine Disorders in Fanconi Anemia: Recommendations for Screening and Treatment. The Journal of Clinical Endocrinology & Metabolism. 100(3). 803–811. 64 indexed citations

12.

Frohnert, Brigitte I., et al.. (2015). Higher daily physical activity is associated with higher osteocalcin levels in adolescents. SHILAP Revista de lepidopterología. 2. 568–571. 17 indexed citations

13.

Forlenza, Gregory P., Srinath Chinnakotla, Sarah Jane Schwarzenberg, et al.. (2014). Near-Euglycemia Can Be Achieved Safely in Pediatric Total Pancreatectomy Islet Autotransplant Recipients Using an Adapted Intravenous Insulin Infusion Protocol. Diabetes Technology & Therapeutics. 16(11). 706–713. 17 indexed citations

14.

DuBose, Stephanie N., Brandon M. Nathan, Roy W. Beck, et al.. (2014). Therapeutic inertia: underdiagnosed and undertreated hypertension in children participating in the T1D Exchange Clinic Registry. Pediatric Diabetes. 17(1). 15–20. 25 indexed citations

15.

Kelly, Aaron S., Kyle Rudser, Brandon M. Nathan, et al.. (2013). The Effect of Glucagon-Like Peptide-1 Receptor Agonist Therapy on Body Mass Index in Adolescents With Severe Obesity. JAMA Pediatrics. 167(4). 355–355. 133 indexed citations

16.

Polgreen, Lynda E., David R. Jacobs, Brandon M. Nathan, et al.. (2012). Association of Osteocalcin With Obesity, Insulin Resistance, and Cardiovascular Risk Factors in Young Adults. Obesity. 20(11). 2194–2201. 46 indexed citations

17.

Kelly, Aaron S., Andrea M. Metzig, Kyle Rudser, et al.. (2011). Exenatide as a Weight‐Loss Therapy in Extreme Pediatric Obesity: A Randomized, Controlled Pilot Study. Obesity. 20(2). 364–370. 107 indexed citations

18.

Nathan, Brandon M., Craig A. Hodges, & Mark R. Palmert. (2006). The use of mouse chromosome substitution strains to investigate the genetic regulation of pubertal timing. Molecular and Cellular Endocrinology. 254-255. 103–108. 7 indexed citations

19.

Nathan, Brandon M., et al.. (2005). Diabetic amyotrophy in an adolescent responsive to intravenous immunoglobulin. Muscle & Nerve. 32(6). 818–820. 10 indexed citations

20.

Nathan, Brandon M. & Mark R. Palmert. (2005). Regulation and Disorders of Pubertal Timing. Endocrinology and Metabolism Clinics of North America. 34(3). 617–641. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact